Myopia Control With a Innovative Spectacle Lens - A Cessation Study

The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Myopia Progressing

Age range

9 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Illinois College of Optometry, Chicago, Illinois, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Existing subjects from the NCT05174780 clinical study.
Ability to comply with study procedures.
Informed consent of parent/guardian and assent of subject.

Exclusion criteria

Current ocular infection, inflammation, or irritation likely to affect vision.

Treatment and study plan

Single Vision Lens to A innovative spectacle lens

Device

Participants in this arm are from the test group of the previous clinical trial (NCT05174780), where they wore the innovative spectacle lenses for three years. They will now wear single vision lenses for 12 months.

Primary outcomes

Change in cycloplegic spherical equivalent refraction from baseline

Time frame: 0 - 12 months
Change in Axial Length from baseline

Time frame: 0 - 12 months

Sponsors and collaborators

Lead sponsor

Essilor International

Industry

Collaborators

Visioncare Research Ltd.

Registry information

Official study title

Clinical Evaluation of A Innovative Spectacle Lens in Slowing Myopia Progression - A Cessation Study

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Mar 19, 2025
Registry last updated: Sep 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, not recruiting